- Trump Delays $140m CDC Grant, Risks Undermining Fentanyl Overdose Fight
- Public health workers warn cuts could reverse recent progress in overdose death reduction
- Experts blame new DOGE review for stalling critical addiction response programmes
By Grateful Ogunjebe
Trump administration has stalled over $140 million in funding aimed at combating fentanyl overdoses, jeopardising key addiction treatment efforts across the United States.
Eko Hot Blog reports that the Four officials from the US Centers for Disease Control and Prevention (CDC) revealed that the money, originally slated for local and state health departments, is now being reviewed under a new programme called the Department of Government Efficiency (DOGE).
EDITOR’S PICK
- Police Step Up Fight Against Cultism with Special Squads
- Attackers of LASTMA Officials Will Face Full Prosecution — Sanwo Olu
- Fresh Attack in Plateau Leaves 20 Dead, Communities Cry for Help
The funding delay has sparked fears of job losses, service shutdowns, and a reversal in the decline of drug overdose deaths reported in recent months.
The grant known as Overdose Data to Action (OD2A) l had helped reduce opioid-related deaths from a record high of 114,000 in 2023 to just under 82,000 in 2024.
Health experts now warn that the Trump administration’s actions could dismantle that progress and further strain struggling communities.
Chrissie Juliano, Executive Director of the Big Cities Health Coalition, described the situation as “catastrophic”, stating that lives are on the line if grants are not released soon.
States like Vermont say they have already paused spending due to the funding freeze. Several state and local agencies confirmed they received verbal warnings but no formal directives.
The CDC has remained silent publicly but confirmed internally that it cannot guarantee full release of the funds due to DOGE and budget office reviews.

CDC staff say the delay is unusual and damaging, especially as addiction-related deaths still remain high and resources are stretched thin.
Keith Humphreys, a Stanford University drug policy expert, said that if the delay continues, thousands could lose access to lifesaving services like naloxone and treatment centres.
Trump’s latest budget also included cuts to Medicaid, which covers addiction care for millions, increasing pressure on the already fragile system.
The DOGE review was introduced under Trump to eliminate “inefficiencies”, but staff inside the CDC say it has only caused confusion and panic.
Local health departments, especially in urban centres like Boston, say they are still awaiting clarity on what parts of their programmes may be cut.
The grant programme had previously provided vital data collection, overdose surveillance, and direct funding to addiction treatment clinics.

Analysts fear that if DOGE recommends cutting the grant entirely, it will create a ripple effect across public health departments in all 50 states.
The Biden administration had expanded the programme in 2022 following the spike in synthetic opioid deaths linked to fentanyl imports.
With the delay now extending into weeks, some public health teams say they’ve begun winding down overdose prevention work while awaiting final decisions.
FURTHER READING
- Anglican Church Reaffirms Ban On Same-S3x Union
- Sanwo-Olu Celebrates APC Victory in Lagos LG Polls
- Dabiri-Erewa Celebrates MaryAnn Iji Oduntan’s Recognition by King Charles





